Alexandra Latypova is an Executive Vice President and a co-founder of iCardiac Technologies.  At iCardiac, she has been responsible for coordinating the development of multiple science-based new service lines, including Highly Automated QT, QTbtb, and Beyond QT.  Prior to iCardiac Technologies, Ms. Latypova headed sales and business development at VirtualScopics, Inc. (VSCP) a leading developer of image-based biomarkers for improving pharmaceutical development. During her tenure at VirtualScopics, she expanded the client portfolio from one lead customer, Pfizer, to 6 of the top-10 pharmaceutical companies as well as multiple smaller pharmaceutical and medical device clients. In addition, she has been responsible for developing project management organization at VirtualScopics and hiring and training several project managers and business development associates. Prior to VirtualScopics, Ms. Latypova was a Manager in healthcare practice at Analysis Group, Inc., a Boston-based economics, financial and strategy consultancy, where she advised pharmaceutical clients on a wide range of issues concerning product and market development, as well as provided economic analyses and expertise in pharmaceutical litigation cases. Ms. Latypova holds Masters of Business Administration degree form the Amos Tuck School at Dartmouth College.